Industry Insights

  1. When The hMSC Meets The AAV 1/3/2023

    Learn more about plausible benefits of AAV’s use in concert with hMSCs, and how a complete genetic engineering medium was expanded beyond lentivirus.

  2. Paving The Way For Tomorrow's Medicines

    Recent advances in nanoparticle engineering technology promise to improve the success rate of new drug candidates and help push novel therapies to market.

  3. Assessing Quality Of mRNA Vaccines: Key Considerations 10/12/2022

    To address the need for standards for mRNA vaccines, the United States Pharmacopeia (USP) has convened vaccine experts to identify important quality attributes and to propose test methods that can be used to assess mRNA vaccine products. This article shares those CQAs and analytical procedure tips.

  4. Crucial Variables Of Pre-Qualified Vs. Customized Temperature Sensitive Shipping Solutions 3/22/2015

    By Melissa Germain, M.Sc., Electro-Optical Systems Laboratory, Georgia Tech Research Institute, and Jean-Pierre Emond, Ph.D., The Illuminate Group

    While the pre-qualified solutions may seem like a good option because the design work has already been completed, if the design criteria do not meet the actual usage, the package may not be effective. By simply understanding a few key variables that go into the design, testing, and real-life practices of temperature sensitive shipping containers, it is possible to determine if a pre-qualified shipper or a customized solution would be best based on risk, cost, and ease of integration.

  5. Application Of CRISPR Technology In iPSC Gene Correction 10/14/2025

    The CRISPR-iPSC combination is becoming a core tool for precision medicine with advanced editing efficiency, differentiation control, and safety profiles.

  6. The Essential Components Of A Sterility Assurance Program 10/15/2021

    The first step in developing a sterility assurance program is to list each step in the process, beginning at the point of use and ending in sterile storage. Each step should be evaluated for ways to prevent contamination in the manufacturing process or environments. This article shares the components of a holistic sterility assurance program for an aseptic manufactured product.

  7. Cell & Gene Therapy Bioprocessing: Demand For Better Process Control, Expertise & CMOs 5/14/2021

    Manufacturing capacity for both cell therapies and gene therapy viral vectors remains in short supply. From BioPlan Associates, Inc.'s new survey of biopharmaceutical manufacturing professionals, there is a current and worsening capacity crunch. The industry continues to demand innovative solutions from its suppliers in key areas that can be slow to develop. 

  8. 5 Cost Savers From Selling Your Surplus Biopharmaceutical Equipment

    Selling or disposing of surplus and unused manufacturing and packaging equipment can provide cash to your business from otherwise idled “assets.” 

  9. 2021's Bioprocessing Year In Review And 7 Key Takeaways 1/11/2022

    The biopharma industry has responded aggressively and effectively to the COVID-19 pandemic. However, supply chain challenges, shortages, hiring problems, and regionalization have created the need for new strategies. Explore more in BioPlan Associates’ 2021 18th Annual Report and Survey of Biopharmaceutical Manufacturing Capacity and Production.

  10. India's CROs & CDMOs Come Of Age In The Global Marketplace 5/4/2023

    Most of the top 10 pharmaceutical companies and many large biotech companies today get a portion of their preclinical/clinical research, drug development, and/or manufacturing done in India. While a low price is the initial attraction, there are additional factors that can be more meaningful.